Seven Biopharma Trends to Watch in 2022

Foresite’s immunology play gets a $200M megaround for TYK2 program, rebranding as Alumis

Top Life Sciences Startups to Watch in 2022

This Entrepreneur Raised $93 Million To Cure Common Diseases

Vikram Bajaj, PhD: “Innovation Doesn’t Come from Boston and San Francisco Alone”

Foresite recruits Principia vet Martin Babler — and his old team — to occupy the C-suite of a startup

Vik Bajaj unveils Foresite’s new incubator, looking to hatch future giants crossing tech and healthcare

How This Multi-Million Dollar Startup Could Make It Easier To Identify The Next Epidemic

How 5 Biotech Investors Are Responding to the Covid-19 Crisis

Sestina Bio — Harnessing the Power of Digital Biology for Synthetic Biology